Related Experiment Video
Updated: Oct 13, 2025

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.3K
Obesity is a risk factor for central precocious puberty: a case-control study.
Gaiyan Liu1, Jinxin Guo2, Xuejing Zhang1
1Department of pediatrics, Xingtai Third Hospital, Xingtai, P.R. China.
BMC Pediatrics
|November 17, 2021
Summary
Childhood overweight and obesity increase the risk of central precocious puberty (CPP). Prolonged excess weight, especially in girls, is a significant risk factor, suggesting weight management for prevention.
Area of Science:
- Pediatric Endocrinology
- Public Health
- Childhood Obesity Research
Background:
- Childhood obesity is a known contributor to central precocious puberty (CPP).
- Previous studies on CPP diagnosis lacked robust hormonal confirmation and relied on less precise methods.
- This study addresses limitations by investigating the link between overweight/obesity and hormonally diagnosed CPP.
Purpose of the Study:
- To determine if childhood overweight and obesity are associated with an increased incidence of hormonally diagnosed central precocious puberty (CPP).
- To analyze the impact of overweight/obesity duration on CPP risk in children.
Main Methods:
- A retrospective case-control study involving 846 children with CPP and 1650 healthy controls.
- Data collected via electronic medical records and outpatient questionnaires.
- Unconditional logistic regression used to assess the association between overweight/obesity status, duration, and CPP.
Main Results:
- Overweight and obesity significantly increased CPP odds in girls, even after adjusting for confounding factors (aORs 1.92 and 1.78, respectively).
- The association between overweight/obesity and CPP in girls was significant for durations of 1-3+ years.
- Obesity was also linked to increased CPP odds in boys (aOR 1.68), with significance observed for durations exceeding 2 years.
Conclusions:
- Prolonged overweight and obesity in early childhood are identified as risk factors for central precocious puberty (CPP), particularly in girls.
- Weight loss interventions may play a crucial role in preventing precocious puberty in at-risk children.
More Related Videos
Related Concept Videos
Obesity
705
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
705
Signs of Puberty
726
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
726
Bulimia Nervosa
249
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
249
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
16
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
16
Anorexia Nervosa
274
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
274
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
19
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
19

